Poolbeg Pharma PLC (POLB)’in fiyatı nedir?

Poolbeg Pharma PLC (POLB)’in fiyatı $0.11565963’dir

Poolbeg Pharma PLC (POLB)’in piyasa değeri nedir?

Poolbeg Pharma PLC (POLB)’in piyasa değeri $882.99K’dir.

Poolbeg Pharma PLC (POLB) Hisse Bölünmeleri

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Yıl	Bölünme	Çarpan	Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.

Yıl

Bölünme

Çarpan

Kümülatif Çarpan

Sağlanan tarihler için yeterli veri yok.

Şirket	Hisse bölünme sayısı	Kümülatif Çarpan	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Şirket

Hisse bölünme sayısı

Kümülatif Çarpan

Ülke